We estimate that Dexcom G7 15 Day will be available to people with diabetes in the second half of 2025. Once available, your patients will require a new prescription.  

If you have a patient that is not already on a CGM, you don’t need to wait for Dexcom G7 15 Day to prescribe them the life changing benefits of Dexcom G7.  

Yes, once available, your patients will require a new Dexcom G7 15 Day prescription. 

Dexcom G7 15 Day is for adult patients 18 years and older with all types of diabetes including type 1, type 2, or gestational diabetes. 

Dexcom G7 15 Day differs from Dexcom G7 in three ways: 

• MARD Accuracy – Dexcom G7 15 Day is slightly more accurate with a MARD of 8.0%¹ compared to Dexcom G7 which holds a MARD of 8.2%²
• Wear Time – Dexcom G7 15 Day sensor has a 15.5* (includes 12-hour grace period) day wear time that is ~50% longer than Dexcom G7’s 10.5 (includes 12-hour grace period) day wear time. This means reduced burden for your patients from less sensor changes, less day ones, and less waste per month.
• Age Indication – Dexcom G7 15 Day is for adults age 18+. Dexcom G7 is for patients who are ages 2 and older. Dexcom recommends adults 18+ use Dexcom G7 15 Day for the wear time benefits. 

Beyond these three differences Dexcom G7 15 Day and Dexcom G7 perform the same and contain the same alert, event logging, and connectivity features. 

*A study was conducted to assess the sensor life where 73.9% of sensors lasted the full 15 days. When using the product per the package labeling, approximately 26% of sensors may not last for the full 15 days. 

1 Dexcom G7 15 Day User Guide 2 Dexcom G7 User Guide 

The Dexcom G7 15 Day Continuous Glucose Monitoring (CGM) System is now cleared in the US for adults (18+) with all types of diabetes. 

 Dexcom G7 15 Day is cleared as an integrated continuous glucose monitoring system (iCGM) and is designed to last an industry leading^*,1 15.5 days^† (including a 12-hour grace period).  

 With FDA clearance, Dexcom G7 15 Day is on schedule to be released in the US the second half of 2025. 

*Excludes implantable CGM systems 

† A study was conducted to assess the sensor life where 73.9% of sensors lasted the full 15 days. When using the product per the package labeling, approximately 26% of sensors may not last for the full 15 days. 

1 Dexcom, Data on File,2025 

Currently, Dexcom Direct EHR Integration Solution is offered to customers using Epic EHR system.

The Dexcom direct CGM data integration into the EHR enables sharing of the CGM data directly into the patient’s medical record in the EHR for Dexcom G7 app users. Physicians and clinical care teams are able to view patients’ historical CGM data in patient’s chart in Epic. Once the patient completes account linking and authorizes data sharing with their healthcare provider, data will be automatically pushed to Epic (add footnote that G6 and receivers are not covered).

The historical CGM data set shared with the EHR supports the Ambulatory Glucose Profile (AGP), which provides glucose statistics, time in ranges, and other commonly used CGM metrics.

Dexcom direct CGM data integration into the EHR provides discrete data within EHR, keeping clinicians in their EHR workflows. It automatically inputs data into patient charts, which allows for efficient and meaningful visits. It supports population health management and quality reporting by having CGM data, such as the GMI, readily available for use by reporting tools in Epic. It supports automated charge capture for CGM data review. Finally, it delivers an intuitive experience for both the patient and clinician.

Although this feature has been enabled for all G7 app users in the US, it will only be activated for the health systems that implemented the direct solution. Healthcare providers will be able to access patient records once the Dexcom Direct Epic EHR Integration Solution has been implemented by their health system.